TVRD · NASDAQ · Biotechnology

Tvardi Therapeutics (TVRD)

Develops oral STAT3 inhibitors for cancer and fibrotic diseases.

$1.89
Pre-market+0.02 (+0.96%)
At close$1.87(+7.16%)

Breakdown13F · 13D/G · Form 4

Institutions66 holders · as of Mar 31, 202628.81%2.70M shares
Insiders2 holders · as of May 2, 20257.36%690.1K shares
Otherremainder63.83%5.99M shares

9.38M company shares as of Aug 21, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

The share count has not been confirmed by a second filing; stakes use it as it stands.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesEvidence
Slate Path Capital LPInstitution
7.51%704,11813Fas of Mar 31, 2026
Shaheen WirkInsiderdirector
4.73%443,385Form 4filed May 2, 2025
BlackRock, Inc.Institution
4.14%388,07513Fas of Mar 31, 2026
Vanguard Capital Management LLCInstitution
3.67%344,70813Fas of Mar 31, 2026
Wallace L. Jr HallInsiderdirector
2.63%246,756Form 4filed May 2, 2025
American Financial Group IncInstitution
2.38%223,65913Fas of Mar 31, 2026
Geode Capital Management, LLCInstitution
1.94%182,33913Fas of Mar 31, 2026
Silvercrest Asset Management Group LLCInstitution
1.08%101,03413Fas of Mar 31, 2026
State Street CorpInstitution
1.04%97,23113Fas of Mar 31, 2026
Renaissance Technologies LLCInstitution
0.98%92,10013Fas of Mar 31, 2026
Morgan StanleyInstitution
0.78%72,89413Fas of Mar 31, 2026
Duncan Williams Asset Management, LLCInstitution
0.67%63,24113Fas of Mar 31, 2026
UBS Group AGInstitution
0.54%50,45413Fas of Mar 31, 2026
Northern Trust CorpInstitution
0.52%49,08113Fas of Mar 31, 2026
Vanguard Fiduciary Trust CoInstitution
0.50%46,87213Fas of Mar 31, 2026
AQR Capital Management LLCInstitution
0.45%42,19213Fas of Mar 31, 2026
Great Lakes Advisors, LLCInstitution
0.39%36,23613Fas of Mar 31, 2026
Vanguard Portfolio Management LLCInstitution
0.36%33,83313Fas of Mar 31, 2026
Squarepoint Ops LLCInstitution
0.35%32,67613Fas of Mar 31, 2026
Goldman Sachs Group IncInstitution
0.25%23,89813Fas of Mar 31, 2026
Russell Investments Group, Ltd.Institution
0.25%23,30713Fas of Mar 31, 2026
Farallon Capital Management LLCInstitution
0.23%21,43813Fas of Mar 31, 2026
Bank of New York Mellon CorpInstitution
0.19%17,40513Fas of Mar 31, 2026
Charles Schwab Investment Management IncInstitution
0.13%11,78413Fas of Mar 31, 2026
SRS Capital Advisors, Inc.Institution
0.09%8,33313Fas of Mar 31, 2026

13F — a manager's quarterly holdings · Form 4 — an insider's transaction report

Institutions13F, as of Mar 31, 2026

66 holders · 2.70M shares · 16 new positions · 35 increased · 16 reduced · 16 closed

HolderShares% outstandingChg q/qFiled
Slate Path Capital LP704.1K7.51%0May 15, 2026
BlackRock, Inc.388.1K4.14%−2.9KMay 13, 2026
Vanguard Capital Management LLC344.7K3.67%+344.7KnewMay 15, 2026
American Financial Group Inc223.7K2.38%0May 13, 2026
Geode Capital Management, LLC182.3K1.94%+25.2KMay 15, 2026
Silvercrest Asset Management Group LLC101.0K1.08%0May 15, 2026
State Street Corp97.2K1.04%−18.3KMay 15, 2026
Renaissance Technologies LLC92.1K0.98%−12.4KMay 14, 2026

Ownership statements13D/G · 5% or more, as filed

No 13D/G filer at 5% or more on record.

Insider tradesForm 4

Latest trades

No open-market trades in the last 12 months.

CongressHouse and Senate disclosures

Not reported.